Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
greater 32 39 32 39 O
than 40 44 40 44 O
or 45 47 45 47 O
equal 48 53 48 53 O
to 54 56 54 56 O
1000 57 61 57 61 B-lower_bound
/ 61 62 61 62 I-lower_bound
mm^3 62 66 62 66 I-lower_bound

Adequate 0 8 67 75 O
cardiac 9 16 76 83 O
function 17 25 84 92 O
defined 26 33 93 100 O
as 34 36 101 103 O
: 36 37 103 104 O
normal 38 44 105 111 O
12 45 47 112 114 B-treatment
lead 48 52 115 119 I-treatment
electrocardiogram 53 70 120 137 I-treatment
( 71 72 138 139 I-treatment
EKG 72 75 139 142 I-treatment
) 75 76 142 143 I-treatment
with 77 81 144 148 O
corrected 82 91 149 158 B-clinical_variable
QT 92 94 159 161 I-clinical_variable
interval 95 103 162 170 I-clinical_variable
( 104 105 171 172 I-clinical_variable
QTc 105 108 172 175 I-clinical_variable
) 108 109 175 176 I-clinical_variable
< 110 111 177 178 O
450 112 115 179 182 B-upper_bound
msec 116 120 183 187 I-upper_bound
, 120 121 187 188 O
and 122 125 189 192 O
either 126 132 193 199 O
shortening 133 143 200 210 B-clinical_variable
fraction 144 152 211 219 I-clinical_variable
of 153 155 220 222 O
> 156 157 223 224 O
= 157 158 224 225 O
28 159 161 226 228 B-lower_bound
% 161 162 228 229 I-lower_bound
by 163 165 230 232 O
echocardiogram 166 180 233 247 B-treatment
and 181 184 248 251 O
qualitatively 185 198 252 265 O
normal 199 205 266 272 O
left 206 210 273 277 B-clinical_variable
ventricular 211 222 278 289 I-clinical_variable
function 223 231 290 298 I-clinical_variable
, 231 232 298 299 O
or 233 235 300 302 O
ejection 236 244 303 311 B-clinical_variable
fraction 245 253 312 320 I-clinical_variable
of 254 256 321 323 O
> 257 258 324 325 O
= 258 259 325 326 O
55 260 262 327 329 B-lower_bound
% 262 263 329 330 I-lower_bound
by 264 266 331 333 O
echocardiogram 267 281 334 348 O

Adequate 0 8 349 357 O
pulmonary 9 18 358 367 O
function 19 27 368 376 O
as 28 30 377 379 O
defined 31 38 380 387 O
as 39 41 388 390 O
: 41 42 390 391 O
no 43 45 392 394 O
evidence 46 54 395 403 O
of 55 57 404 406 O
dyspnea 58 65 407 414 B-chronic_disease
at 66 68 415 417 O
rest 69 73 418 422 O
, 73 74 422 423 O
no 75 77 424 426 O
exercise 78 86 427 435 O
intolerance 87 98 436 447 O
, 98 99 447 448 O
and 100 103 449 452 O
a 104 105 453 454 O
pulse 106 111 455 460 B-clinical_variable
oximetry 112 120 461 469 I-clinical_variable
> 121 122 470 471 O
94 123 125 472 474 B-lower_bound
% 125 126 474 475 I-lower_bound
if 127 129 476 478 O
there 130 135 479 484 O
is 136 138 485 487 O
clinical 139 147 488 496 O
indication 148 158 497 507 O
for 159 162 508 511 O
determination 163 176 512 525 O

Age 0 3 526 529 B-age
1 4 5 530 531 B-lower_bound
to 6 8 532 534 O
< 9 10 535 536 O
2 11 12 537 538 B-upper_bound
years 13 18 539 544 I-upper_bound
, 18 19 544 545 O
0.6 20 23 546 549 O
mg 24 26 550 552 O
/ 26 27 552 553 O
dL 27 29 553 555 O
( 30 31 556 557 O
male 31 35 557 561 B-gender
) 35 36 561 562 O
and 37 40 563 566 O
0.6 41 44 567 570 O
mg 45 47 571 573 O
/ 47 48 573 574 O
dL 48 50 574 576 O
( 51 52 577 578 O
female 52 58 578 584 B-gender
) 58 59 584 585 O

Age 0 3 586 589 B-age
> 4 5 590 591 O
10 6 8 592 594 B-lower_bound
and 9 12 595 598 O
< 13 14 599 600 O
13 15 17 601 603 B-upper_bound
years 18 23 604 609 I-upper_bound
, 23 24 609 610 O
1.2 25 28 611 614 B-upper_bound
mg 29 31 615 617 I-upper_bound
/ 31 32 617 618 I-upper_bound
dL 32 34 618 620 I-upper_bound
( 35 36 621 622 O
male 36 40 622 626 B-gender
) 40 41 626 627 O
and 42 45 628 631 O
1.2 46 49 632 635 O
mg 50 52 636 638 O
/ 52 53 638 639 O
dL 53 55 639 641 O
( 56 57 642 643 O
female 57 63 643 649 B-gender
) 63 64 649 650 O

Age 0 3 651 654 B-age
> 4 5 655 656 O
13 6 8 657 659 B-lower_bound
and 9 12 660 663 O
< 13 14 664 665 O
16 15 17 666 668 B-upper_bound
years 18 23 669 674 I-upper_bound
, 23 24 674 675 O
1.5 25 28 676 679 B-upper_bound
mg 29 31 680 682 I-upper_bound
/ 31 32 682 683 I-upper_bound
dL 32 34 683 685 I-upper_bound
( 35 36 686 687 O
male 36 40 687 691 B-gender
) 40 41 691 692 O
and 42 45 693 696 O
1.4 46 49 697 700 B-upper_bound
mg 50 52 701 703 I-upper_bound
/ 52 53 703 704 I-upper_bound
dL 53 55 704 706 I-upper_bound
( 56 57 707 708 O
female 57 63 708 714 B-gender
) 63 64 714 715 O

Age 0 3 716 719 B-age
> 4 5 720 721 O
16 6 8 722 724 B-lower_bound
years 9 14 725 730 I-lower_bound
, 14 15 730 731 O
1.7 16 19 732 735 O
mg 20 22 736 738 O
/ 22 23 738 739 O
dL 23 25 739 741 O
( 26 27 742 743 O
male 27 31 743 747 B-gender
) 31 32 747 748 O
and 33 36 749 752 O
1.4 37 40 753 756 O
mg 41 43 757 759 O
/ 43 44 759 760 O
dL 44 46 760 762 O
( 47 48 763 764 O
female 48 54 764 770 B-gender
) 54 55 770 771 O

Age 0 3 772 775 B-age
> 4 5 776 777 O
2 6 7 778 779 B-age
and 8 11 780 783 O
< 12 13 784 785 O
6 14 15 786 787 B-upper_bound
years 16 21 788 793 I-upper_bound
, 21 22 793 794 O
0.8 23 26 795 798 O
mg 27 29 799 801 O
/ 29 30 801 802 O
dL(male 30 37 802 809 O
) 37 38 809 810 O
and 39 42 811 814 O
0.8 43 46 815 818 O
mg 47 49 819 821 O
/ 49 50 821 822 O
dL 50 52 822 824 O
( 53 54 825 826 O
female 54 60 826 832 B-gender
) 60 61 832 833 O

Age 0 3 834 837 B-age
> 4 5 838 839 O
6 6 7 840 841 B-lower_bound
and 8 11 842 845 O
< 12 13 846 847 O
10 14 16 848 850 B-upper_bound
years 17 22 851 856 I-upper_bound
, 22 23 856 857 O
1.0 24 27 858 861 O
mg 28 30 862 864 O
/ 30 31 864 865 O
dL 31 33 865 867 O
( 34 35 868 869 O
male 35 39 869 873 B-gender
) 39 40 873 874 O
and 41 44 875 878 O
1.0 45 48 879 882 O
mg 49 51 883 885 O
/ 51 52 885 886 O
dL 52 54 886 888 O
( 55 56 889 890 O
female 56 62 890 896 B-gender
) 62 63 896 897 O

All 0 3 898 901 O
post 4 8 902 906 O
- 8 9 906 907 O
menarchal 9 18 907 916 O
females 19 26 917 924 B-gender
must 27 31 925 929 O
have 32 36 930 934 O
a 37 38 935 936 O
negative 39 47 937 945 B-pregnancy
serum 48 53 946 951 I-pregnancy
beta 54 58 952 956 I-pregnancy
- 58 59 956 957 I-pregnancy
human 59 64 957 962 I-pregnancy
chorionic 65 74 963 972 I-pregnancy
gonadotropin 75 87 973 985 I-pregnancy
( 88 89 986 987 I-pregnancy
beta 89 93 987 991 I-pregnancy
HCG 94 97 992 995 I-pregnancy
) 97 98 995 996 I-pregnancy
; 98 99 996 997 O
sexually 100 108 998 1006 O
active 109 115 1007 1013 O
patients 116 124 1014 1022 O
of 125 127 1023 1025 O
childbearing 128 140 1026 1038 O
potential 141 150 1039 1048 O
must 151 155 1049 1053 O
agree 156 161 1054 1059 B-contraception_consent
to 162 164 1060 1062 I-contraception_consent
use 165 168 1063 1066 I-contraception_consent
an 169 171 1067 1069 I-contraception_consent
effective 172 181 1070 1079 I-contraception_consent
method 182 188 1080 1086 I-contraception_consent
of 189 191 1087 1089 I-contraception_consent
contraception 192 205 1090 1103 I-contraception_consent
during 206 212 1104 1110 O
the 213 216 1111 1114 O
study 217 222 1115 1120 O
and 223 226 1121 1124 O
for 227 230 1125 1128 O
at 231 233 1129 1131 O
least 234 239 1132 1137 O
6 240 241 1138 1139 B-lower_bound
months 242 248 1140 1146 I-lower_bound
after 249 254 1147 1152 I-lower_bound

Amiodarone 0 10 1153 1163 B-treatment
, 10 11 1163 1164 O
sotalol 12 19 1165 1172 B-treatment
, 19 20 1172 1173 O
ibutilide 21 30 1174 1183 B-treatment
, 30 31 1183 1184 O
dofetilide 32 42 1185 1195 B-treatment

Angiotensin 0 11 1196 1207 B-treatment
- 11 12 1207 1208 I-treatment
converting 12 22 1208 1218 I-treatment
enzyme 23 29 1219 1225 I-treatment
( 30 31 1226 1227 I-treatment
ACE 31 34 1227 1230 I-treatment
) 34 35 1230 1231 I-treatment
inhibitors 36 46 1232 1242 I-treatment
: 46 47 1242 1243 O
patients 48 56 1244 1252 O
who 57 60 1253 1256 O
are 61 64 1257 1260 O
currently 65 74 1261 1270 O
receiving 75 84 1271 1280 O
ACE 85 88 1281 1284 B-treatment
inhibitors 89 99 1285 1295 I-treatment

Antacids 0 8 1296 1304 B-treatment
: 8 9 1304 1305 O
use 10 13 1306 1309 O
of 14 16 1310 1312 O
H2 17 19 1313 1315 B-treatment
blockers 20 28 1316 1324 I-treatment
and 29 32 1325 1328 O
proton 33 39 1329 1335 B-treatment
pump 40 44 1336 1340 I-treatment
inhibitors 45 55 1341 1351 I-treatment
is 56 58 1352 1354 O
not 59 62 1355 1358 O
recommended 63 74 1359 1370 O
; 74 75 1370 1371 O
patients 76 84 1372 1380 O
who 85 88 1381 1384 O
require 89 96 1385 1392 O
antacids 97 105 1393 1401 B-treatment
should 106 112 1402 1408 O
use 113 116 1409 1412 O
short 117 122 1413 1418 O
acting 123 129 1419 1425 O
, 129 130 1425 1426 O
locally 131 138 1427 1434 O
active 139 145 1435 1441 O
agents 146 152 1442 1448 O
( 153 154 1449 1450 O
e.g. 154 158 1450 1454 O
, 158 159 1454 1455 O
Maalox 160 166 1456 1462 B-treatment
, 166 167 1462 1463 O
Mylanta 168 175 1464 1471 B-treatment
etc 176 179 1472 1475 O
. 179 180 1475 1476 O
) 180 181 1476 1477 O
; 181 182 1477 1478 O
however 183 190 1479 1486 O
, 190 191 1486 1487 O
these 192 197 1488 1493 O
agents 198 204 1494 1500 O
should 205 211 1501 1507 O
not 212 215 1508 1511 O
be 216 218 1512 1514 O
taken 219 224 1515 1520 O
within 225 231 1521 1527 O
either 232 238 1528 1534 O
2 239 240 1535 1536 B-upper_bound
hours 241 246 1537 1542 I-upper_bound
before 247 253 1543 1549 I-upper_bound
or 254 256 1550 1552 O
2 257 258 1553 1554 B-upper_bound
hours 259 264 1555 1560 I-upper_bound
after 265 270 1561 1566 I-upper_bound
the 271 274 1567 1570 O
dasatinib 275 284 1571 1580 B-treatment
dose 285 289 1581 1585 O

Anti 0 4 1586 1590 B-chronic_disease
- 4 5 1590 1591 I-chronic_disease
graft 5 10 1591 1596 I-chronic_disease
- 10 11 1596 1597 I-chronic_disease
versus 11 17 1597 1603 I-chronic_disease
- 17 18 1603 1604 I-chronic_disease
host 18 22 1604 1608 I-chronic_disease
disease 23 30 1609 1616 I-chronic_disease
( 31 32 1617 1618 I-chronic_disease
GVHD 32 36 1618 1622 I-chronic_disease
) 36 37 1622 1623 I-chronic_disease
or 38 40 1624 1626 O
agents 41 47 1627 1633 O
to 48 50 1634 1636 O
prevent 51 58 1637 1644 O
organ 59 64 1645 1650 O
rejection 65 74 1651 1660 O
post 75 79 1661 1665 B-treatment
- 79 80 1665 1666 I-treatment
transplant 80 90 1666 1676 I-treatment
: 90 91 1676 1677 O
patients 92 100 1678 1686 O
who 101 104 1687 1690 O
are 105 108 1691 1694 O
receiving 109 118 1695 1704 O
cyclosporine 119 131 1705 1717 B-treatment
, 131 132 1717 1718 O
tacrolimus 133 143 1719 1729 B-treatment
or 144 146 1730 1732 O
other 147 152 1733 1738 O
agents 153 159 1739 1745 O
to 160 162 1746 1748 O
prevent 163 170 1749 1756 O
either 171 177 1757 1763 O
graft 178 183 1764 1769 O
- 183 184 1769 1770 O
versus 184 190 1770 1776 O
- 190 191 1776 1777 O
host 191 195 1777 1781 O
disease 196 203 1782 1789 O
post 204 208 1790 1794 B-treatment
bone 209 213 1795 1799 I-treatment
marrow 214 220 1800 1806 I-treatment
transplant 221 231 1807 1817 I-treatment
or 232 234 1818 1820 O
organ 235 240 1821 1826 O
rejection 241 250 1827 1836 O
post 251 255 1837 1841 O
- 255 256 1841 1842 O
transplant 256 266 1842 1852 O

Anticoagulants 0 14 1853 1867 B-treatment
/ 14 15 1867 1868 O
anti 15 19 1868 1872 B-treatment
- 19 20 1872 1873 I-treatment
platelets 20 29 1873 1882 I-treatment
: 29 30 1882 1883 O
patients 31 39 1884 1892 O
on 40 42 1893 1895 O
therapeutic 43 54 1896 1907 B-treatment
( 55 56 1908 1909 I-treatment
treatment 56 65 1909 1918 I-treatment
) 65 66 1918 1919 I-treatment
dose 67 71 1920 1924 I-treatment
of 72 74 1925 1927 I-treatment
anticoagulants 75 89 1928 1942 I-treatment
( 90 91 1943 1944 O
e.g. 91 95 1944 1948 O
warfarin 96 104 1949 1957 B-treatment
, 104 105 1957 1958 O
low 106 109 1959 1962 B-treatment
molecular 110 119 1963 1972 I-treatment
- 119 120 1972 1973 I-treatment
weight 120 126 1973 1979 I-treatment
heparin 127 134 1980 1987 I-treatment
) 134 135 1987 1988 O

Aspartate 0 9 1989 1998 B-clinical_variable
aminotransferase 10 26 1999 2015 I-clinical_variable
( 27 28 2016 2017 I-clinical_variable
AST 28 31 2017 2020 I-clinical_variable
) 31 32 2020 2021 I-clinical_variable
and 33 36 2022 2025 O
alanine 37 44 2026 2033 B-clinical_variable
aminotransferase 45 61 2034 2050 I-clinical_variable
( 62 63 2051 2052 I-clinical_variable
ALT 63 66 2052 2055 I-clinical_variable
) 66 67 2055 2056 I-clinical_variable
= 68 69 2057 2058 O
< 69 70 2058 2059 O
3 71 72 2060 2061 B-upper_bound
x 73 74 2062 2063 I-upper_bound
upper 75 80 2064 2069 I-upper_bound
limit 81 86 2070 2075 I-upper_bound
of 87 89 2076 2078 I-upper_bound
normal 90 96 2079 2085 I-upper_bound
for 97 100 2086 2089 I-upper_bound
age 101 104 2090 2093 I-upper_bound
( 105 106 2094 2095 I-upper_bound
ULN 106 109 2095 2098 I-upper_bound
) 109 110 2098 2099 I-upper_bound

Bilirubin 0 9 2100 2109 B-clinical_variable
= 10 11 2110 2111 O
< 11 12 2111 2112 O
1.5 13 16 2113 2116 B-upper_bound
x 17 18 2117 2118 I-upper_bound
ULN 19 22 2119 2122 I-upper_bound

Category 0 8 2123 2131 O
I 9 10 2132 2133 B-treatment
drugs 11 16 2134 2139 I-treatment
that 17 21 2140 2144 O
are 22 25 2145 2148 O
generally 26 35 2149 2158 O
accepted 36 44 2159 2167 O
to 45 47 2168 2170 O
have 48 52 2171 2175 O
a 53 54 2176 2177 O
risk 55 59 2178 2182 O
of 60 62 2183 2185 O
causing 63 70 2186 2193 O
torsades 71 79 2194 2202 O
de 80 82 2203 2205 O
pointes 83 90 2206 2213 O
including 91 100 2214 2223 O
: 100 101 2223 2224 O
( 102 103 2225 2226 O
patients 103 111 2226 2234 O
must 112 116 2235 2239 O
discontinue 117 128 2240 2251 O
drug 129 133 2252 2256 O
at 134 136 2257 2259 O
least 137 142 2260 2265 O
7 143 144 2266 2267 B-lower_bound
days 145 149 2268 2272 I-lower_bound
prior 150 155 2273 2278 I-lower_bound
to 156 158 2279 2281 O
starting 159 167 2282 2290 O
dasatinib 168 177 2291 2300 B-treatment
) 177 178 2300 2301 O

Chlorpromazine 0 14 2302 2316 B-treatment
, 14 15 2316 2317 O
haloperidol 16 27 2318 2329 B-treatment
, 27 28 2329 2330 O
mesoridazine 29 41 2331 2343 B-treatment
, 41 42 2343 2344 O
thioridazine 43 55 2345 2357 B-treatment
, 55 56 2357 2358 O
pimozide 57 65 2359 2367 B-treatment

Cisapride 0 9 2368 2377 B-treatment
, 9 10 2377 2378 O
bepridil 11 19 2379 2387 B-treatment
, 19 20 2387 2388 O
droperidol 21 31 2389 2399 B-treatment
, 31 32 2399 2400 O
arsenic 33 40 2401 2408 B-treatment
, 40 41 2408 2409 O
chloroquine 42 53 2410 2421 B-treatment
, 53 54 2421 2422 O
domperidone 55 66 2423 2434 B-treatment
, 66 67 2434 2435 O
halofantrine 68 80 2436 2448 B-treatment
, 80 81 2448 2449 O
levomethadyl 82 94 2450 2462 B-treatment
, 94 95 2462 2463 O
sparfloxacin 96 108 2464 2476 B-treatment
, 108 109 2476 2477 O
lidoflazine 110 121 2478 2489 B-treatment

Concomitant 0 11 2490 2501 B-treatment
medications 12 23 2502 2513 I-treatment
: 23 24 2513 2514 O
the 25 28 2515 2518 O
following 29 38 2519 2528 O
drugs 39 44 2529 2534 O
need 45 49 2535 2539 O
to 50 52 2540 2542 O
be 53 55 2543 2545 O
stopped 56 63 2546 2553 O
at 64 66 2554 2556 O
the 67 70 2557 2560 O
time 71 75 2561 2565 O
of 76 78 2566 2568 O
beginning 79 88 2569 2578 O
therapy 89 96 2579 2586 B-treatment
: 96 97 2586 2587 O
patient 98 105 2588 2595 O
can 106 109 2596 2599 O
not 109 112 2599 2602 O
be 113 115 2603 2605 O
on 116 118 2606 2608 O
liver 119 124 2609 2614 O
enzyme 125 131 2615 2621 O
inducing 132 140 2622 2630 O
anticonvulsants 141 156 2631 2646 B-treatment
; 156 157 2646 2647 O
patients 158 166 2648 2656 O
must 167 171 2657 2661 O
not 172 175 2662 2665 O
have 176 180 2666 2670 O
received 181 189 2671 2679 O
growth 190 196 2680 2686 O
factors 197 204 2687 2694 O
to 205 207 2695 2697 O
support 208 215 2698 2705 O
the 216 219 2706 2709 O
number 220 226 2710 2716 O
or 227 229 2717 2719 O
function 230 238 2720 2728 O
of 239 241 2729 2731 O
white 242 247 2732 2737 O
cells 248 253 2738 2743 O
or 254 256 2744 2746 O
platelets 257 266 2747 2756 O
within 267 273 2757 2763 O
the 274 277 2764 2767 O
past 278 282 2768 2772 B-upper_bound
7 283 284 2773 2774 I-upper_bound
days 285 289 2775 2779 I-upper_bound
and 290 293 2780 2783 O
pegfilgrastim 294 307 2784 2797 B-treatment
within 308 314 2798 2804 O
the 315 318 2805 2808 O
past 319 323 2809 2813 B-upper_bound
14 324 326 2814 2816 I-upper_bound
days 327 331 2817 2821 I-upper_bound

Creatinine 0 10 2822 2832 B-clinical_variable
clearance 11 20 2833 2842 I-clinical_variable
or 21 23 2843 2845 O
radioisotope 24 36 2846 2858 B-clinical_variable
glomerular 37 47 2859 2869 I-clinical_variable
filtration 48 58 2870 2880 I-clinical_variable
rate 59 63 2881 2885 I-clinical_variable
( 64 65 2886 2887 I-clinical_variable
GFR 65 68 2887 2890 I-clinical_variable
) 68 69 2890 2891 I-clinical_variable
> 70 71 2892 2893 O
70 72 74 2894 2896 B-lower_bound
ml 75 77 2897 2899 I-lower_bound
/ 77 78 2899 2900 I-lower_bound
min/1.73 78 86 2900 2908 I-lower_bound
m^2 87 90 2909 2912 I-lower_bound
OR 91 93 2913 2915 O
serum 94 99 2916 2921 B-clinical_variable
creatinine 100 110 2922 2932 I-clinical_variable
based 111 116 2933 2938 O
on 117 119 2939 2941 O
age 120 123 2942 2945 B-age
/ 123 124 2945 2946 O
gender 124 130 2946 2952 O

Drugs 0 5 2953 2958 O
prolong 6 13 2959 2966 O
QT 14 16 2967 2969 B-clinical_variable
interval 17 25 2970 2978 I-clinical_variable
; 25 26 2978 2979 O
erythromycin 27 39 2980 2992 B-treatment
, 39 40 2992 2993 O
clarithromycin 41 55 2994 3008 B-treatment
, 55 56 3008 3009 O
pentamidine 57 68 3010 3021 B-treatment
, 68 69 3021 3022 O
ondansetron 70 81 3023 3034 B-treatment
, 81 82 3034 3035 O
granisetron 83 94 3036 3047 B-treatment
, 94 95 3047 3048 O
and 96 99 3049 3052 O
methadone 100 109 3053 3062 B-treatment

Hemoglobin 0 10 3063 3073 B-clinical_variable
greater 11 18 3074 3081 O
than 19 23 3082 3086 O
8.0 24 27 3087 3090 B-lower_bound
g 28 29 3091 3092 I-lower_bound
/ 29 30 3092 3093 I-lower_bound
dL 30 32 3093 3095 I-lower_bound
( 33 34 3096 3097 O
transfusion 34 45 3097 3108 B-treatment
independent 46 57 3109 3120 O
; 57 58 3120 3121 O
no 59 61 3122 3124 O
transfusion 62 73 3125 3136 O
for 74 77 3137 3140 O
> 78 79 3141 3142 O
= 79 80 3142 3143 O
7 81 82 3144 3145 B-lower_bound
days 83 87 3146 3150 I-lower_bound
prior 88 93 3151 3156 I-lower_bound
to 94 96 3157 3159 O
study 97 102 3160 3165 O
enrollment 103 113 3166 3176 O
) 113 114 3176 3177 O

History 0 7 3178 3185 O
of 8 10 3186 3188 O
hypersensitivity 11 27 3189 3205 O
to 28 30 3206 3208 O
any 31 34 3209 3212 B-allergy_name
component 35 44 3213 3222 I-allergy_name
of 45 47 3223 3225 I-allergy_name
the 48 51 3226 3229 I-allergy_name
formulation 52 63 3230 3241 I-allergy_name

Inducers 0 8 3242 3250 O
and 9 12 3251 3254 O
Inhibitors 13 23 3255 3265 O
of 24 26 3266 3268 O
cytochrome 27 37 3269 3279 B-treatment
P450 38 42 3280 3284 I-treatment
family 43 49 3285 3291 I-treatment
3 50 51 3292 3293 I-treatment
, 51 52 3293 3294 O
subfamily 53 62 3295 3304 B-treatment
A 63 64 3305 3306 I-treatment
, 64 65 3306 3307 O
polypeptide 66 77 3308 3319 B-treatment
4 78 79 3320 3321 I-treatment
( 80 81 3322 3323 I-treatment
CYP3A4 81 87 3323 3329 I-treatment
): 87 89 3329 3331 I-treatment
patients 90 98 3332 3340 O
required 99 107 3341 3349 O
to 108 110 3350 3352 O
be 111 113 3353 3355 O
on 114 116 3356 3358 O
any 117 120 3359 3362 O
CYP3A4/5 121 129 3363 3371 B-treatment
inhibitors 130 140 3372 3382 O
or 141 143 3383 3385 O
inducers 144 152 3386 3394 O
will 153 157 3395 3399 O
be 158 160 3400 3402 O
excluded 161 169 3403 3411 O
( 170 171 3412 3413 O
with 171 175 3413 3417 O
the 176 179 3418 3421 O
exception 180 189 3422 3431 O
of 190 192 3432 3434 O
dexamethasone 193 206 3435 3448 B-treatment
, 206 207 3448 3449 O
but 208 211 3450 3453 O
all 212 215 3454 3457 O
efforts 216 223 3458 3465 O
should 224 230 3466 3472 O
be 231 233 3473 3475 O
made 234 238 3476 3480 O
to 239 241 3481 3483 O
reduce 242 248 3484 3490 O
the 249 252 3491 3494 O
dose 253 257 3495 3499 O
of 258 260 3500 3502 O
dexamethasone 261 274 3503 3516 O
) 274 275 3516 3517 O
; 275 276 3517 3518 O
patients 277 285 3519 3527 O
must 286 290 3528 3532 O
discontinue 291 302 3533 3544 O
drug 303 307 3545 3549 O
at 308 310 3550 3552 O
least 311 316 3553 3558 O
7 317 318 3559 3560 B-lower_bound
days 319 323 3561 3565 I-lower_bound
prior 324 329 3566 3571 I-lower_bound
to 330 332 3572 3574 O
starting 333 341 3575 3583 O
dasatinib 342 351 3584 3593 B-treatment

Karnofsky 0 9 3594 3603 B-clinical_variable
performance 10 21 3604 3615 I-clinical_variable
status 22 28 3616 3622 I-clinical_variable
> 29 30 3623 3624 O
= 30 31 3624 3625 O
50 32 34 3626 3628 B-lower_bound
for 35 38 3629 3632 O
patients 39 47 3633 3641 O
> 48 49 3642 3643 O
= 49 50 3643 3644 O
16 51 53 3645 3647 O
years 54 59 3648 3653 O
of 60 62 3654 3656 O
age 63 66 3657 3660 B-age
and 67 70 3661 3664 O
a 71 72 3665 3666 O
Lansky 73 79 3667 3673 B-clinical_variable
performance 80 91 3674 3685 I-clinical_variable
status 92 98 3686 3692 I-clinical_variable
> 99 100 3693 3694 O
= 100 101 3694 3695 O
50 102 104 3696 3698 O
for 105 108 3699 3702 O
patients 109 117 3703 3711 O
aged 118 122 3712 3716 B-age
< 123 124 3717 3718 O
16 125 127 3719 3721 O
years 128 133 3722 3727 O

Life 0 4 3728 3732 B-clinical_variable
expectancy 5 15 3733 3743 I-clinical_variable
: 15 16 3743 3744 O
must 17 21 3745 3749 O
be 22 24 3750 3752 O
> 25 26 3753 3754 O
= 26 27 3754 3755 O
12 28 30 3756 3758 B-lower_bound
weeks 31 36 3759 3764 I-lower_bound

Must 0 4 3765 3769 O
not 5 8 3770 3773 O
have 9 13 3774 3778 O
received 14 22 3779 3787 O
bevacizumab 23 34 3788 3799 B-treatment
or 35 37 3800 3802 O
other 38 43 3803 3808 O
monoclonal 44 54 3809 3819 B-treatment
antibody 55 63 3820 3828 I-treatment
therapy 64 71 3829 3836 I-treatment
within 72 78 3837 3843 O
4 79 80 3844 3845 B-upper_bound
weeks 81 86 3846 3851 I-upper_bound
of 87 89 3852 3854 O
study 90 95 3855 3860 O
the 96 99 3861 3864 O
entry 100 105 3865 3870 O

Must 0 4 3871 3875 O
not 5 8 3876 3879 O
have 9 13 3880 3884 O
received 14 22 3885 3893 O
oral 23 27 3894 3898 B-treatment
tyrosine 28 36 3899 3907 I-treatment
kinase 37 43 3908 3914 I-treatment
inhibitors 44 54 3915 3925 I-treatment
( 55 56 3926 3927 O
other 56 61 3927 3932 O
than 62 66 3933 3937 O
dasatinib 67 76 3938 3947 B-treatment
) 76 77 3947 3948 O
or 78 80 3949 3951 O
other 81 86 3952 3957 O
similar 87 94 3958 3965 O
agents 95 101 3966 3972 O
within 102 108 3973 3979 O
3 109 110 3980 3981 B-upper_bound
weeks 111 116 3982 3987 I-upper_bound
of 117 119 3988 3990 O
the 120 123 3991 3994 O
study 124 129 3995 4000 O
entry 130 135 4001 4006 O
and 136 139 4007 4010 O
all 140 143 4011 4014 O
toxicities 144 154 4015 4025 B-clinical_variable
must 155 159 4026 4030 O
have 160 164 4031 4035 O
resolved 165 173 4036 4044 O
to 174 176 4045 4047 O
< 177 178 4048 4049 O
grade 179 184 4050 4055 B-upper_bound
2 185 186 4056 4057 I-upper_bound
prior 187 192 4058 4063 O
to 193 195 4064 4066 O
enrollment 196 206 4067 4077 O

Patients 0 8 4078 4086 O
must 9 13 4087 4091 O
have 14 18 4092 4096 O
had 19 22 4097 4100 O
a 23 24 4101 4102 O
previous 25 33 4103 4111 O
histological 34 46 4112 4124 O
verification 47 59 4125 4137 O
of 60 62 4138 4140 O
a 63 64 4141 4142 O
solid 65 70 4143 4148 B-cancer
tumor 71 76 4149 4154 I-cancer
at 77 79 4155 4157 O
the 80 83 4158 4161 O
original 84 92 4162 4170 O
diagnosis 93 102 4171 4180 O
and/or 103 109 4181 4187 O
recurrence 110 120 4188 4198 O
including 121 130 4199 4208 O
brain 131 136 4209 4214 B-cancer
tumors 137 143 4215 4221 I-cancer
; 143 144 4221 4222 O
for 145 148 4223 4226 O
patients 149 157 4227 4235 O
with 158 162 4236 4240 O
brain 163 168 4241 4246 B-cancer
stem 169 173 4247 4251 I-cancer
gliomas 174 181 4252 4259 I-cancer
and 182 185 4260 4263 O
optic 186 191 4264 4269 B-cancer
pathway 192 199 4270 4277 I-cancer
tumors 200 206 4278 4284 I-cancer
, 206 207 4284 4285 O
the 208 211 4286 4289 O
requirement 212 223 4290 4301 O
for 224 227 4302 4305 O
histological 228 240 4306 4318 O
evaluation 241 251 4319 4329 O
may 252 255 4330 4333 O
be 256 258 4334 4336 O
waived 259 265 4337 4343 O

Patients 0 8 4344 4352 O
must 9 13 4353 4357 O
not 14 17 4358 4361 O
have 18 22 4362 4366 O
received 23 31 4367 4375 O
prior 32 37 4376 4381 B-treatment
therapy 38 45 4382 4389 I-treatment
with 46 50 4390 4394 O
dasatinib 51 60 4395 4404 B-treatment
and 61 64 4405 4408 O
temsirolimus 65 77 4409 4421 B-treatment
for 78 81 4422 4425 O
any 82 85 4426 4429 O
indication 86 96 4430 4440 O

Patients 0 8 4441 4449 O
with 9 13 4450 4454 O
clinically 14 24 4455 4465 O
significant 25 36 4466 4477 O
cardiovascular 37 51 4478 4492 B-chronic_disease
disease 52 59 4493 4500 I-chronic_disease
: 59 60 4500 4501 O
history 61 68 4502 4509 O
of 69 71 4510 4512 O
ischemic 72 80 4513 4521 B-chronic_disease
or 81 83 4522 4524 O
hemorrhagic 84 95 4525 4536 B-chronic_disease
stroke 96 102 4537 4543 I-chronic_disease
within 103 109 4544 4550 O
past 110 114 4551 4555 B-upper_bound
6 115 116 4556 4557 I-upper_bound
months 117 123 4558 4564 I-upper_bound
; 123 124 4564 4565 O
uncontrolled 125 137 4566 4578 B-chronic_disease
hypertension 138 150 4579 4591 I-chronic_disease
, 150 151 4591 4592 O
on 152 154 4593 4595 O
at 155 157 4596 4598 O
least 158 163 4599 4604 O
2 164 165 4605 4606 B-lower_bound
repeated 166 174 4607 4615 O
determinations 175 189 4616 4630 O
on 190 192 4631 4633 O
separate 193 201 4634 4642 O
days 202 206 4643 4647 O
within 207 213 4648 4654 O
past 214 218 4655 4659 B-upper_bound
3 219 220 4660 4661 I-upper_bound
months 221 227 4662 4668 I-upper_bound
; 227 228 4668 4669 O
myocardial 229 239 4670 4680 B-chronic_disease
infarction 240 250 4681 4691 I-chronic_disease
or 251 253 4692 4694 O
unstable 254 262 4695 4703 B-chronic_disease
angina 263 269 4704 4710 I-chronic_disease
within 270 276 4711 4717 O
past 277 281 4718 4722 O
6 282 283 4723 4724 O
months 284 290 4725 4731 O
; 290 291 4731 4732 O
New 292 295 4733 4736 B-clinical_variable
York 296 300 4737 4741 I-clinical_variable
Heart 301 306 4742 4747 I-clinical_variable
Association 307 318 4748 4759 I-clinical_variable
grade 319 324 4760 4765 B-lower_bound
III 325 328 4766 4769 I-lower_bound
or 329 331 4770 4772 O
greater 332 339 4773 4780 O
congestive 340 350 4781 4791 B-chronic_disease
heart 351 356 4792 4797 I-chronic_disease
failure 357 364 4798 4805 I-chronic_disease
, 364 365 4805 4806 O
serious 366 373 4807 4814 O
cardiac 374 381 4815 4822 B-chronic_disease
arrhythmia 382 392 4823 4833 I-chronic_disease
requiring 393 402 4834 4843 O
medication 403 413 4844 4854 B-treatment
, 413 414 4854 4855 O
unstable 415 423 4856 4864 B-chronic_disease
angina 424 430 4865 4871 I-chronic_disease
pectoris 431 439 4872 4880 I-chronic_disease
within 440 446 4881 4887 O
past 447 451 4888 4892 O
6 452 453 4893 4894 O
months 454 460 4895 4901 O
; 460 461 4901 4902 O
clinically 462 472 4903 4913 O
significant 473 484 4914 4925 O
peripheral 485 495 4926 4936 B-chronic_disease
vascular 496 504 4937 4945 I-chronic_disease
disease 505 512 4946 4953 I-chronic_disease
within 513 519 4954 4960 O
past 520 524 4961 4965 O
6 525 526 4966 4967 O
months 527 533 4968 4974 O
; 533 534 4974 4975 O
pulmonary 535 544 4976 4985 B-chronic_disease
embolism 545 553 4986 4994 I-chronic_disease
, 553 554 4994 4995 O
deep 555 559 4996 5000 B-chronic_disease
vein 560 564 5001 5005 I-chronic_disease
thrombosis 565 575 5006 5016 I-chronic_disease
( 576 577 5017 5018 I-chronic_disease
DVT 577 580 5018 5021 I-chronic_disease
) 580 581 5021 5022 I-chronic_disease
, 581 582 5022 5023 O
or 583 585 5024 5026 O
other 586 591 5027 5032 O
thromboembolic 592 606 5033 5047 B-chronic_disease
event 607 612 5048 5053 I-chronic_disease
within 613 619 5054 5060 O
past 620 624 5061 5065 O
6 625 626 5066 5067 O
months 627 633 5068 5074 O
; 633 634 5074 5075 O
diagnosed 635 644 5076 5085 O
congenital 645 655 5086 5096 B-chronic_disease
long 656 660 5097 5101 I-chronic_disease
QT 661 663 5102 5104 I-chronic_disease
syndrome 664 672 5105 5113 I-chronic_disease
; 672 673 5113 5114 O
any 674 677 5115 5118 O
history 678 685 5119 5126 O
of 686 688 5127 5129 O
clinically 689 699 5130 5140 O
significant 700 711 5141 5152 O
ventricular 712 723 5153 5164 B-chronic_disease
arrhythmias 724 735 5165 5176 I-chronic_disease
( 736 737 5177 5178 O
such 737 741 5178 5182 O
as 742 744 5183 5185 O
ventricular 745 756 5186 5197 B-chronic_disease
tachycardia 757 768 5198 5209 I-chronic_disease
, 768 769 5209 5210 O
ventricular 770 781 5211 5222 B-chronic_disease
fibrillation 782 794 5223 5235 I-chronic_disease
, 794 795 5235 5236 O
or 796 798 5237 5239 O
torsades 799 807 5240 5248 B-chronic_disease
de 808 810 5249 5251 I-chronic_disease
pointes 811 818 5252 5259 I-chronic_disease
) 818 819 5259 5260 O
; 819 820 5260 5261 O
prolonged 821 830 5262 5271 B-clinical_variable
QTc 831 834 5272 5275 I-clinical_variable
interval 835 843 5276 5284 I-clinical_variable
on 844 846 5285 5287 O
pre 847 850 5288 5291 B-treatment
- 850 851 5291 5292 I-treatment
entry 851 856 5292 5297 I-treatment
electrocardiogram 857 874 5298 5315 I-treatment
( 875 876 5316 5317 O
> 876 877 5317 5318 O
450 878 881 5319 5322 B-lower_bound
msec 882 886 5323 5327 I-lower_bound
) 886 887 5327 5328 O

Patients 0 8 5329 5337 O
with 9 13 5338 5342 O
evidence 14 22 5343 5351 O
of 23 25 5352 5354 O
recent 26 32 5355 5361 O
intratumoral 33 45 5362 5374 B-chronic_disease
hemorrhage 46 56 5375 5385 I-chronic_disease
( 57 58 5386 5387 O
within 58 64 5387 5393 O
3 65 66 5394 5395 B-upper_bound
months 67 73 5396 5402 I-upper_bound
of 74 76 5403 5405 O
study 77 82 5406 5411 O
enrollment 83 93 5412 5422 O
) 93 94 5422 5423 O
, 94 95 5423 5424 O
gastrointestinal 96 112 5425 5441 B-chronic_disease
bleeding 113 121 5442 5450 I-chronic_disease
, 121 122 5450 5451 O
history 123 130 5452 5459 O
of 131 133 5460 5462 O
coronary 134 142 5463 5471 B-chronic_disease
artery 143 149 5472 5478 I-chronic_disease
disease 150 157 5479 5486 I-chronic_disease
or 158 160 5487 5489 O
on 161 163 5490 5492 O
anticoagulation 164 179 5493 5508 B-treatment
therapy 180 187 5509 5516 I-treatment

Patients 0 8 5517 5525 O
with 9 13 5526 5530 O
known 14 19 5531 5536 O
human 20 25 5537 5542 B-chronic_disease
immunodeficiency 26 42 5543 5559 I-chronic_disease
virus 43 48 5560 5565 I-chronic_disease
( 49 50 5566 5567 I-chronic_disease
HIV 50 53 5567 5570 I-chronic_disease
) 53 54 5570 5571 I-chronic_disease

Platelets 0 9 5572 5581 B-clinical_variable
greater 10 17 5582 5589 O
than 18 22 5590 5594 O
or 23 25 5595 5597 O
equal 26 31 5598 5603 O
to 32 34 5604 5606 O
75,000 35 41 5607 5613 B-lower_bound
/ 41 42 5613 5614 I-lower_bound
mm^3 42 46 5614 5618 I-lower_bound
( 47 48 5619 5620 O
transfusion 48 59 5620 5631 O
independent 60 71 5632 5643 O
; 71 72 5643 5644 O
no 73 75 5645 5647 O
transfusion 76 87 5648 5659 O
for 88 91 5660 5663 O
> 92 93 5664 5665 O
= 93 94 5665 5666 O
7 95 96 5667 5668 B-lower_bound
days 97 101 5669 5673 I-lower_bound
prior 102 107 5674 5679 I-lower_bound
to 108 110 5680 5682 O
study 111 116 5683 5688 O
enrollment 117 127 5689 5699 O
) 127 128 5699 5700 O

Pregnant 0 8 5701 5709 B-pregnancy

Quinidine 0 9 5710 5719 B-treatment
, 9 10 5719 5720 O
procainamide 11 23 5721 5733 B-treatment
, 23 24 5733 5734 O
disopyramide 25 37 5735 5747 B-treatment

Radiotherapy 0 12 5748 5760 B-treatment
( 13 14 5761 5762 I-treatment
XRT 14 17 5762 5765 I-treatment
): 17 19 5765 5767 I-treatment
at 20 22 5768 5770 O
least 23 28 5771 5776 O
4 29 30 5777 5778 B-lower_bound
weeks 31 36 5779 5784 I-lower_bound
for 37 40 5785 5788 O
focal 41 46 5789 5794 B-treatment
XRT 47 50 5795 5798 I-treatment
or 51 53 5799 5801 O
8 54 55 5802 5803 B-upper_bound
weeks 56 61 5804 5809 I-upper_bound
for 62 65 5810 5813 O
craniospinal 66 78 5814 5826 B-treatment
XRT 79 82 5827 5830 I-treatment
must 83 87 5831 5835 O
have 88 92 5836 5840 O
elapsed 93 100 5841 5848 O
prior 101 106 5849 5854 O
to 107 109 5855 5857 O
study 110 115 5858 5863 O
entry 116 121 5864 5869 O

Serum 0 5 5870 5875 B-clinical_variable
cholesterol 6 17 5876 5887 I-clinical_variable
and 18 21 5888 5891 O
serum 22 27 5892 5897 B-clinical_variable
triglyceride 28 40 5898 5910 I-clinical_variable
levels 41 47 5911 5917 I-clinical_variable
must 48 52 5918 5922 O
be 53 55 5923 5925 O
< 56 57 5926 5927 O
grade 58 63 5928 5933 B-upper_bound
2 64 65 5934 5935 I-upper_bound

Stem 0 4 5936 5940 B-treatment
cell 5 9 5941 5945 I-treatment
transplant 10 20 5946 5956 I-treatment
( 21 22 5957 5958 I-treatment
SCT 22 25 5958 5961 I-treatment
): 25 27 5961 5963 I-treatment
at 28 30 5964 5966 O
least 31 36 5967 5972 O
8 37 38 5973 5974 B-lower_bound
weeks 39 44 5975 5980 I-lower_bound
following 45 54 5981 5990 O
autologous 55 65 5991 6001 B-treatment
SCT 66 69 6002 6005 I-treatment
and 70 73 6006 6009 O
12 74 76 6010 6012 B-upper_bound
weeks 77 82 6013 6018 I-upper_bound
for 83 86 6019 6022 O
allogeneic 87 97 6023 6033 B-treatment
SCT 98 101 6034 6037 I-treatment

Surgery 0 7 6038 6045 B-treatment
: 7 8 6045 6046 O
at 9 11 6047 6049 O
least 12 17 6050 6055 O
2 18 19 6056 6057 B-lower_bound
weeks 20 25 6058 6063 I-lower_bound
following 26 35 6064 6073 O
surgery 36 43 6074 6081 B-treatment
including 44 53 6082 6091 O
brain 54 59 6092 6097 O
and 60 63 6098 6101 O
spine 64 69 6102 6107 O
provided 70 78 6108 6116 O
post 79 83 6117 6121 O
- 83 84 6121 6122 O
operative 84 93 6122 6131 O
magnetic 94 102 6132 6140 B-treatment
resonance 103 112 6141 6150 I-treatment
imaging 113 120 6151 6158 I-treatment
( 121 122 6159 6160 I-treatment
MRI 122 125 6160 6163 I-treatment
) 125 126 6163 6164 I-treatment
shows 127 132 6165 6170 O
no 133 135 6171 6173 O
active 136 142 6174 6180 O
bleeding 143 151 6181 6189 O

The 0 3 6190 6193 O
patient 4 11 6194 6201 O
must 12 16 6202 6206 O
have 17 21 6207 6211 O
a 22 23 6212 6213 O
stable 24 30 6214 6220 O
clinical 31 39 6221 6229 O
( 40 41 6230 6231 O
neurologic 41 51 6231 6241 O
in 52 54 6242 6244 O
case 55 59 6245 6249 O
of 60 62 6250 6252 O
brain 63 68 6253 6258 B-cancer
tumors 69 75 6259 6265 I-cancer
) 75 76 6265 6266 O
exam 77 81 6267 6271 O
and 82 85 6272 6275 O
be 86 88 6276 6278 O
on 89 91 6279 6281 O
a 92 93 6282 6283 O
stable 94 100 6284 6290 O
dose 101 105 6291 6295 O
of 106 108 6296 6298 O
steroids 109 117 6299 6307 O
for 118 121 6308 6311 O
at 122 124 6312 6314 O
least 125 130 6315 6320 O
1 131 132 6321 6322 B-lower_bound
week 133 137 6323 6327 I-lower_bound
prior 138 143 6328 6333 I-lower_bound
to 144 146 6334 6336 O
study 147 152 6337 6342 O
entry 153 158 6343 6348 O
; 158 159 6348 6349 O
the 160 163 6350 6353 O
patient 164 171 6354 6361 O
should 172 178 6362 6368 O
have 179 183 6369 6373 O
a 184 185 6374 6375 O
measurable 186 196 6376 6386 O
and/or 197 203 6387 6393 O
evaluable 204 213 6394 6403 O
disease 214 221 6404 6411 O
; 221 222 6411 6412 O
measurable 223 233 6413 6423 O
disease 234 241 6424 6431 O
which 242 247 6432 6437 O
is 248 250 6438 6440 O
defined 251 258 6441 6448 O
as 259 261 6449 6451 O
the 262 265 6452 6455 O
presence 266 274 6456 6464 O
of 275 277 6465 6467 O
at 278 280 6468 6470 O
least 281 286 6471 6476 O
one 287 290 6477 6480 B-lower_bound
lesion 291 297 6481 6487 O
that 298 302 6488 6492 O
can 303 306 6493 6496 O
be 307 309 6497 6499 O
accurately 310 320 6500 6510 O
measured 321 329 6511 6519 O
in 330 332 6520 6522 O
two 333 336 6523 6526 O
dimensions 337 347 6527 6537 O
( 348 349 6538 6539 O
each 349 353 6539 6543 O
measures 354 362 6544 6552 O
at 363 365 6553 6555 O
least 366 371 6556 6561 O
10 372 374 6562 6564 B-lower_bound
mm 375 377 6565 6567 I-lower_bound
) 377 378 6567 6568 O
or 379 381 6569 6571 O
evaluable 382 391 6572 6581 O
disease 392 399 6582 6589 O
which 400 405 6590 6595 O
is 406 408 6596 6598 O
defined 409 416 6599 6606 O
as 417 419 6607 6609 O
at 420 422 6610 6612 O
least 423 428 6613 6618 O
one 429 432 6619 6622 O
lesion 433 439 6623 6629 O
that 440 444 6630 6634 O
can 445 448 6635 6638 O
be 449 451 6639 6641 O
accurately 452 462 6642 6652 O
measured 463 471 6653 6661 O
in 472 474 6662 6664 O
at 475 477 6665 6667 O
least 478 483 6668 6673 O
one 484 487 6674 6677 O
dimension 488 497 6678 6687 O
( 498 499 6688 6689 O
measure 499 506 6689 6696 O
at 507 509 6697 6699 O
least 510 515 6700 6705 O
10 516 518 6706 6708 O
mm 519 521 6709 6711 O
) 521 522 6711 6712 O

Uncontrolled 0 12 6713 6725 O
current 13 20 6726 6733 O
illness 21 28 6734 6741 O
including 29 38 6742 6751 O
, 38 39 6751 6752 O
but 40 43 6753 6756 O
not 44 47 6757 6760 O
limited 48 55 6761 6768 O
to 56 58 6769 6771 O
, 58 59 6771 6772 O
uncontrolled 60 72 6773 6785 B-chronic_disease
infection 73 82 6786 6795 I-chronic_disease
, 82 83 6795 6796 O
need 84 88 6797 6801 O
for 89 92 6802 6805 O
hemodialysis 93 105 6806 6818 B-treatment
, 105 106 6818 6819 O
need 107 111 6820 6824 O
for 112 115 6825 6828 O
ventilatory 116 127 6829 6840 B-treatment
support 128 135 6841 6848 I-treatment
, 135 136 6848 6849 O
psychiatric 137 148 6850 6861 B-chronic_disease
illness 149 156 6862 6869 I-chronic_disease
/ 156 157 6869 6870 O
social 157 163 6870 6876 O
situations 164 174 6877 6887 O
that 175 179 6888 6892 O
would 180 185 6893 6898 O
limit 186 191 6899 6904 O
compliance 192 202 6905 6915 O
with 203 207 6916 6920 O
study 208 213 6921 6926 O
requirements 214 226 6927 6939 O

at 0 2 6940 6942 O
least 3 8 6943 6948 O
3 9 10 6949 6950 B-lower_bound
weeks 11 16 6951 6956 I-lower_bound
must 17 21 6957 6961 O
have 22 26 6962 6966 O
elapsed 27 34 6967 6974 O
from 35 39 6975 6979 O
the 40 43 6980 6983 O
last 44 48 6984 6988 O
dose 49 53 6989 6993 O

breast 0 6 6994 7000 O
- 6 7 7000 7001 O
feeding 7 14 7001 7008 O
women 15 20 7009 7014 B-gender

patients 0 8 7015 7023 O
are 9 12 7024 7027 O
not 13 16 7028 7031 O
allowed 17 24 7032 7039 O
to 25 27 7040 7042 O
take 28 32 7043 7047 O
aspirin 33 40 7048 7055 B-treatment
, 40 41 7055 7056 O
clopidogrel 42 53 7057 7068 B-treatment
, 53 54 7068 7069 O
ticlopidine 55 66 7070 7081 B-treatment
, 66 67 7081 7082 O
Aggrenox 68 76 7083 7091 B-treatment
; 76 77 7091 7092 O
patients 78 86 7093 7101 O
on 87 89 7102 7104 O
prophylactic 90 102 7105 7117 B-treatment
anticoagulation 103 118 7118 7133 I-treatment
may 119 122 7134 7137 O
be 123 125 7138 7140 O
enrolled 126 134 7141 7149 O
and 135 138 7150 7153 O
treated 139 146 7154 7161 O
on 147 149 7162 7164 O
study 150 155 7165 7170 O
as 156 158 7171 7173 O
long 159 163 7174 7178 O
as 164 166 7179 7181 O
their 167 172 7182 7187 O
platelet 173 181 7188 7196 B-clinical_variable
count 182 187 7197 7202 I-clinical_variable
is 188 190 7203 7205 O
monitored 191 200 7206 7215 O
closely 201 208 7216 7223 O
and 209 212 7224 7227 O
maintained 213 223 7228 7238 O
at 224 226 7239 7241 O
> 227 228 7242 7243 O
75,000 229 235 7244 7250 B-lower_bound
while 236 241 7251 7256 O
they 242 246 7257 7261 O
are 247 250 7262 7265 O
receiving 251 260 7266 7275 O
dasatinib 261 270 7276 7285 B-treatment

patients 0 8 7286 7294 O
must 9 13 7295 7299 O
not 14 17 7300 7303 O
be 18 20 7304 7306 O
receiving 21 30 7307 7316 O
any 31 34 7317 7320 O
anti 35 39 7321 7325 B-treatment
- 39 40 7325 7326 I-treatment
thrombotic 40 50 7326 7336 I-treatment
or 51 53 7337 7339 O
anti 54 58 7340 7344 B-treatment
- 58 59 7344 7345 I-treatment
platelet 59 67 7345 7353 I-treatment
agents 68 74 7354 7360 I-treatment
; 74 75 7360 7361 O
patient 76 83 7362 7369 O
can 84 87 7370 7373 O
not 87 90 7373 7376 O
be 91 93 7377 7379 O
on 94 96 7380 7382 O
drugs 97 102 7383 7388 O
that 103 107 7389 7393 O
cause 108 113 7394 7399 O
significant 114 125 7400 7411 O
prolonged 126 135 7412 7421 B-chronic_disease
QT 136 138 7422 7424 I-chronic_disease
( 139 140 7425 7426 O
category 140 148 7426 7434 O
I 149 150 7435 7436 O
drug 151 155 7437 7441 O
) 155 156 7441 7442 O

prior 0 5 7443 7448 B-treatment
treatment 6 15 7449 7458 I-treatment
with 16 20 7459 7463 O
either 21 27 7464 7470 O
dasatinib 28 37 7471 7480 B-treatment
or 38 40 7481 7483 O
temsirolimus 41 53 7484 7496 B-treatment

the 0 3 7497 7500 O
patient 4 11 7501 7508 O
's 11 13 7508 7510 O
disease 14 21 7511 7518 O
must 22 26 7519 7523 O
be 27 29 7524 7526 O
considered 30 40 7527 7537 O
refractory 41 51 7538 7548 O
to 52 54 7549 7551 O
conventional 55 67 7552 7564 B-treatment
/ 67 68 7564 7565 I-treatment
standard 68 76 7565 7573 I-treatment
therapy 77 84 7574 7581 I-treatment
, 84 85 7581 7582 O
or 86 88 7583 7585 O
a 89 90 7586 7587 O
disease 91 98 7588 7595 O
for 99 102 7596 7599 O
which 103 108 7600 7605 O
no 109 111 7606 7608 O
conventional 112 124 7609 7621 B-treatment
therapy 125 132 7622 7629 I-treatment
exists 133 139 7630 7636 O
and 140 143 7637 7640 O
is 144 146 7641 7643 O
progressive 147 158 7644 7655 O

